Home

JAMES H CAVANAUGH

CIK 1013473 · last filed 2026-03-17

JAMES H CAVANAUGH is a corporate insider who has filed 46 SEC Form 4 insider transactions across 7 companies since 2007. The most recent filing, for CYPH, was dated Mar 17, 2026. Across all open-market trades the lifetime net is +$1.8M, making them a net buyer over the disclosed history. Current disclosed insider exposure totals $408.9K across reported positions. 37 SEC filings were submitted jointly with JOHN W LITTLECHILD.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$408.9K

Companies

7

Total Filings

46

Lifetime Open-Market Net

$1.80M

Filer Profile

Reported Address
265 HOTHORPE LANE
VILLANOVA, PA 19085
State of Incorporation
DE
Related Filers
JOHN W LITTLECHILD — 37 joint filings, latest 2016-02-19
HAROLD R WERNER — 37 joint filings, latest 2016-02-19
Christopher Mirabelli — 34 joint filings, latest 2016-02-19
AUGUSTINE LAWLOR — 31 joint filings, latest 2016-02-19
ERIC AGUIAR — 12 joint filings, latest 2007-08-07
WILLIAM CROUSE — 12 joint filings, latest 2004-07-09
HealthCare Ventures VIII, L.P. — 6 joint filings, latest 2016-02-17
DOUGLAS E ONSI — 2 joint filings, latest 2013-12-17
Profile details as reported on the filer's SEC submissions — for individual insiders the address is often in care of the issuer. Related filers are identified from jointly filed SEC submissions and shared reported addresses. View filings on SEC EDGAR.

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
CYPH Director 168,963 $2.42 $408.9K -$822.2K 3 2026-03-17
CYPHERPUNK TECHNOLOGIES INC. (LPTX) Delisted Director 262,053 $1.56 $408.7K $0 17 2025-11-13
VERENIUM CORP (VRNM) Delisted Director 150,000 — — $491.0K 13 2013-06-25
Altimmune, Inc. (PIP) Delisted Director — — — $0 4 2010-06-24
MiddleBrook Pharmaceuticals, Inc. (MBRK) Delisted Director — — — $0 2 2009-06-24
MEDI Director 0 $34.37 $0 $0 2 2007-06-19
MiddleBrook Pharmaceuticals, Inc. (AVNC) Delisted Director 11,863,327 — — $2.13M 2 2007-05-23

Recent Filings

46 filings
Insider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
Filed Symbol Action Net Shares Net $ Link
2026-03-17 CYPH Exer (M) +168,750 $0 EDGAR
2025-12-30 CYPH Grant (A) — $0 EDGAR
2025-11-19 CYPH Sell (S) −261,840 -$822.2K EDGAR
2025-11-13 CYPHERPUNK TECHNOLOGIES INC. (LPTX) Delisted Grant (A) — $0 EDGAR
2024-11-15 CYPHERPUNK TECHNOLOGIES INC. (LPTX) Delisted Exer (X) +213 $601 EDGAR
2024-10-04 CYPHERPUNK TECHNOLOGIES INC. (LPTX) Delisted Grant (A) — $0 EDGAR
2024-01-31 CYPHERPUNK TECHNOLOGIES INC. (LPTX) Delisted Grant (A) — $0 EDGAR
2023-08-25 CYPHERPUNK TECHNOLOGIES INC. (LPTX) Delisted Grant (A) — $0 EDGAR
2023-04-04 CYPHERPUNK TECHNOLOGIES INC. (LPTX) Delisted Grant (A) — $0 EDGAR
2022-09-02 CYPHERPUNK TECHNOLOGIES INC. (LPTX) Delisted Grant (A) — $0 EDGAR
Showing 1–10 of 46
Page 1 of 5
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.